{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:09:56Z","timestamp":1791684596702,"version":"4.3.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04375-6","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:25:56Z","timestamp":1747239956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunomodulatory interactions between mesenchymal stromal\/stem cells and immune cells in psoriasis: therapeutic potential and challenges"],"prefix":"10.1186","volume":"16","author":[{"given":"Mohammadreza","family":"Dashti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Dehnavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahvash","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"4375_CR1","doi-asserted-by":"publisher","first-page":"880201","DOI":"10.3389\/fimmu.2022.880201","volume":"13","author":"J Bu","year":"2022","unstructured":"Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of psoriasis and comorbid diseases: A narrative review. Front Immunol. 2022;13:880201.","journal-title":"Front Immunol"},{"key":"4375_CR2","unstructured":"Organization WH. Global report on psoriasis. 2016:48."},{"issue":"3","key":"4375_CR3","first-page":"164","volume":"7","author":"M Fiocchi","year":"2021","unstructured":"Fiocchi M, Zagni E, Colombo D. Psoriasis: gender perspective on disease characteristics and treatment. Italian J Gender-Specific Med. 2021;7(3):164\u20138.","journal-title":"Italian J Gender-Specific Med"},{"issue":"4","key":"4375_CR4","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/JW9.0000000000000112","volume":"9","author":"A Gonzalez-Cantero","year":"2023","unstructured":"Gonzalez-Cantero A, Constantin MM, Dattola A, Hillary T, Kleyn E, Magnolo N. Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists. Int J Womens Dermatol. 2023;9(4):e112.","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"4375_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205\u201312.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"4375_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/2229-5178.193906","volume":"7","author":"S Dogra","year":"2016","unstructured":"Dogra S, Mahajan R, Psoriasis. Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016;7(6):471\u201380.","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"4375_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5312\/wjo.v5.i4.537","volume":"5","author":"JT Liu","year":"2014","unstructured":"Liu JT, Yeh HM, Liu SY, Chen KT. Psoriatic arthritis: epidemiology, diagnosis, and treatment. World J Orthop. 2014;5(4):537\u201343.","journal-title":"World J Orthop"},{"issue":"3","key":"4375_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021;21(3):170\u20133.","journal-title":"Clin Med (Lond)"},{"issue":"6","key":"4375_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1590\/abd1806-4841.20165080","volume":"91","author":"AV Carvalho","year":"2016","unstructured":"Carvalho AV, Romiti R, Souza CD, Paschoal RS, Milman LM, Meneghello LP. Psoriasis comorbidities: complications and benefits of Immunobiological treatment. Bras Dermatol. 2016;91(6):781\u20139.","journal-title":"Bras Dermatol"},{"key":"4375_CR10","doi-asserted-by":"crossref","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18).","DOI":"10.3390\/ijms20184347"},{"issue":"1","key":"4375_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","volume":"22","author":"S Liu","year":"2024","unstructured":"Liu S, He M, Jiang J, Duan X, Chai B, Zhang J, et al. Triggers for the onset and recurrence of psoriasis: a review and update. Cell Communication Signal. 2024;22(1):108.","journal-title":"Cell Communication Signal"},{"issue":"1","key":"4375_CR12","first-page":"97","volume":"93","author":"F Gr\u00e4n","year":"2020","unstructured":"Gr\u00e4n F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93(1):97\u2013110.","journal-title":"Yale J Biol Med"},{"issue":"2","key":"4375_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM. The immunology of Psoriasis\u2014Current concepts in pathogenesis. Clin Rev Allergy Immunol. 2024;66(2):164\u201391.","journal-title":"Clin Rev Allergy Immunol"},{"key":"4375_CR14","doi-asserted-by":"crossref","unstructured":"Benezeder T, Bordag N, Woltsche J, Teufelberger A, Perchthaler I, Weger W et al. Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis. Res Sq. 2024.","DOI":"10.21203\/rs.3.rs-3958361\/v1"},{"issue":"1","key":"4375_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol. 2011;187(1):490\u2013500.","journal-title":"J Immunol"},{"issue":"1","key":"4375_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/jid.2011.259","volume":"132","author":"S Morizane","year":"2012","unstructured":"Morizane S, Yamasaki K, M\u00fchleisen B, Kotol PF, Murakami M, Aoyama Y, et al. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol. 2012;132(1):135\u201343.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"4375_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.intimp.2012.04.003","volume":"13","author":"\u00c1 Farkas","year":"2012","unstructured":"Farkas \u00c1, Kem\u00e9ny L. Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle. Int Immunopharmacol. 2012;13(2):215\u20138.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4375_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","volume":"9","author":"E Fitch","year":"2007","unstructured":"Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep. 2007;9(6):461\u20137.","journal-title":"Curr Rheumatol Rep"},{"key":"4375_CR19","doi-asserted-by":"publisher","first-page":"835671","DOI":"10.3389\/fimmu.2022.835671","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zang J, Liu C, Yan Z, Shi D. Interleukin-17 links inflammatory Cross-Talks between comorbid psoriasis and atherosclerosis. Front Immunol. 2022;13:835671.","journal-title":"Front Immunol"},{"issue":"3","key":"4375_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10875-009-9278-8","volume":"29","author":"LM Johnson-Huang","year":"2009","unstructured":"Johnson-Huang LM, McNutt NS, Krueger JG, Lowes MA. Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases. J Clin Immunol. 2009;29(3):247\u201356.","journal-title":"J Clin Immunol"},{"key":"4375_CR21","doi-asserted-by":"publisher","first-page":"1081256","DOI":"10.3389\/fimmu.2023.1081256","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P, Su Y, Li S, Chen H, Wu R, Wu H. The roles of T cells in psoriasis. Front Immunol. 2023;14:1081256.","journal-title":"Front Immunol"},{"issue":"4","key":"4375_CR22","first-page":"278","volume":"63","author":"WB Kim","year":"2017","unstructured":"Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278\u201385.","journal-title":"Can Fam Physician"},{"key":"4375_CR23","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Fern\u00e1ndez K, Mangas-Sanju\u00e1n V, Merino-Sanju\u00e1n M, Martorell-Calatayud A, Mateu-Puchades A, Climente-Mart\u00ed M et al. Impact of Pharmacokinetic and pharmacodynamic properties of monoclonal antibodies in the management of psoriasis. Pharmaceutics. 2022;14(3).","DOI":"10.3390\/pharmaceutics14030654"},{"key":"4375_CR24","doi-asserted-by":"publisher","first-page":"156406","DOI":"10.1016\/j.cyto.2023.156406","volume":"172","author":"SS Shobeiri","year":"2023","unstructured":"Shobeiri SS, Dashti M, Pordel S, Rezaee M, Haghnavaz N, Moghadam M, et al. Topical anti-TNF-a SsDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB\/c mice. Cytokine. 2023;172:156406.","journal-title":"Cytokine"},{"key":"4375_CR25","doi-asserted-by":"crossref","unstructured":"Harrington R, Harkins P, Conway R. Janus kinase inhibitors in rheumatoid arthritis: an update on the efficacy and safety of Tofacitinib, baricitinib and Upadacitinib. J Clin Med. 2023;12(20).","DOI":"10.3390\/jcm12206690"},{"issue":"1","key":"4375_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"4375_CR27","first-page":"154","volume":"2","author":"AG Via","year":"2012","unstructured":"Via AG, Frizziero A, Oliva F. Biological properties of mesenchymal stem cells from different sources. Muscles Ligaments Tendons J. 2012;2(3):154\u201362.","journal-title":"Muscles Ligaments Tendons J"},{"issue":"12","key":"4375_CR28","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.intimp.2010.06.019","volume":"10","author":"MJ Hoogduijn","year":"2010","unstructured":"Hoogduijn MJ, Popp F, Verbeek R, Masoodi M, Nicolaou A, Baan C, et al. The Immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol. 2010;10(12):1496\u2013500.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4375_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/icb.2012.56","volume":"91","author":"K English","year":"2013","unstructured":"English K. Mechanisms of mesenchymal stromal cell Immunomodulation. Immunol Cell Biol. 2013;91(1):19\u201326.","journal-title":"Immunol Cell Biol"},{"key":"4375_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3389\/fimmu.2015.00648","volume":"6","author":"SF De Witte","year":"2016","unstructured":"De Witte SF, Franquesa M, Baan CC, Hoogduijn MJ. Toward development of iMesenchymal stem cells for Immunomodulatory therapy. Front Immunol. 2016;6:648.","journal-title":"Front Immunol"},{"key":"4375_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, B\u00f6hm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Communication Signal. 2011;9:1\u201314.","journal-title":"Cell Communication Signal"},{"issue":"1","key":"4375_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13287-022-02782-7","volume":"13","author":"SA Jasim","year":"2022","unstructured":"Jasim SA, Yumashev AV, Abdelbasset WK, Margiana R, Markov A, Suksatan W, et al. Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases. Stem Cell Res Ther. 2022;13(1):101.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4375_CR33","first-page":"1","volume":"2","author":"S-A Ahadiat","year":"2022","unstructured":"Ahadiat S-A, Falaverjani HG, Shabani M, Abadi SAH, Moazamiyanfar R, Rajabi SK, et al. The role of stem cells in treatment of autoimmune diseases. Kindle. 2022;2(1):1\u2013136.","journal-title":"Kindle"},{"key":"4375_CR34","doi-asserted-by":"crossref","unstructured":"Cagliani J, Grande D, Molmenti EP, Miller EJ, Rilo HLR. Immunomodulation by mesenchymal stromal cells and their clinical applications. J Stem Cell Regen Biol. 2017;3(2).","DOI":"10.15436\/2471-0598.17.022"},{"issue":"1","key":"4375_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han Y, Yang J, Fang J, Zhou Y, Candi E, Wang J, et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal Transduct Target Ther. 2022;7(1):92.","journal-title":"Signal Transduct Target Ther"},{"issue":"17","key":"4375_CR36","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.3390\/ijms231710023","volume":"23","author":"Y Huang","year":"2022","unstructured":"Huang Y, Wu Q, Tam PKH. Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci. 2022;23(17):10023.","journal-title":"Int J Mol Sci"},{"key":"4375_CR37","doi-asserted-by":"publisher","first-page":"104771","DOI":"10.1016\/j.cellimm.2023.104771","volume":"393\u2013394","author":"S Dehnavi","year":"2023","unstructured":"Dehnavi S, Sadeghi M, Tavakol Afshari J, Mohammadi M. Interactions of mesenchymal stromal\/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis. Cell Immunol. 2023;393\u2013394:104771.","journal-title":"Cell Immunol"},{"key":"4375_CR38","doi-asserted-by":"crossref","unstructured":"Vellasamy S, Tong ck, Azhar N, Kodiappan R, Chan SC, Veerakumarasivam A et al. Human mesenchymal stromal cells modulate T-cell immune response via transcriptomic regulation. Cytotherapy. 2016;18.","DOI":"10.1016\/j.jcyt.2016.06.017"},{"key":"4375_CR39","doi-asserted-by":"publisher","first-page":"1525380","DOI":"10.3389\/fimmu.2024.1525380","volume":"15","author":"B Chen","year":"2024","unstructured":"Chen B, Chen Z, He M, Zhang L, Yang L, Wei L. Recent advances in the role of mesenchymal stem cells as modulators in autoinflammatory diseases. Front Immunol. 2024;15:1525380.","journal-title":"Front Immunol"},{"issue":"1","key":"4375_CR40","doi-asserted-by":"publisher","first-page":"7495135","DOI":"10.1155\/2016\/7495135","volume":"2016","author":"X Li","year":"2016","unstructured":"Li X, Xu Z, Bai J, Yang S, Zhao S, Zhang Y, et al. Umbilical cord Tissue-Derived mesenchymal stem cells induce T lymphocyte apoptosis and cell cycle arrest by expression of indoleamine 2, 3-Dioxygenase. Stem Cells Int. 2016;2016(1):7495135.","journal-title":"Stem Cells Int"},{"key":"4375_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imlet.2020.06.006","volume":"225","author":"S Lee","year":"2020","unstructured":"Lee S, Kim S, Chung H, Moon JH, Kang SJ, Park C-G. Mesenchymal stem cell-derived exosomes suppress proliferation of T cells by inducing cell cycle arrest through p27kip1\/Cdk2 signaling. Immunol Lett. 2020;225:16\u201322.","journal-title":"Immunol Lett"},{"key":"4375_CR42","doi-asserted-by":"crossref","unstructured":"Zhang H, Jin C, Hua J, Chen Z, Gao W, Xu W et al. Roles of microenvironment on mesenchymal stem cells therapy for osteoarthritis. J Inflamm Res. 2024:7069\u201379.","DOI":"10.2147\/JIR.S475617"},{"issue":"1","key":"4375_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s13287-022-03070-0","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang S, Wang T. How the mechanical microenvironment of stem cell growth affects their differentiation: A review. Stem Cell Res Ther. 2022;13(1):415.","journal-title":"Stem Cell Res Ther"},{"key":"4375_CR44","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00403-014-1493-3","volume":"306","author":"A Campanati","year":"2014","unstructured":"Campanati A, Orciani M, Consales V, Lazzarini R, Ganzetti G, Di Benedetto G, et al. Characterization and profiling of Immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17\/Th2 imbalance of psoriasis. Arch Dermatol Res. 2014;306:915\u201320.","journal-title":"Arch Dermatol Res"},{"key":"4375_CR45","doi-asserted-by":"crossref","unstructured":"Diotallevi F, Di Vincenzo M, Martina E, Radi G, Lariccia V, Offidani A et al. Mesenchymal stem cells and psoriasis: systematic review. Int J Mol Sci. 2022;23(23).","DOI":"10.3390\/ijms232315080"},{"issue":"3","key":"4375_CR46","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2133.2011.10438.x","volume":"165","author":"M Orciani","year":"2011","unstructured":"Orciani M, Campanati A, Salvolini E, Lucarini G, Di Benedetto G, Offidani A, et al. The mesenchymal stem cell profile in psoriasis. Br J Dermatol. 2011;165(3):585\u201392.","journal-title":"Br J Dermatol"},{"issue":"1","key":"4375_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2133.2012.10900.x","volume":"167","author":"A Campanati","year":"2012","unstructured":"Campanati A, Orciani M, Gorbi S, Regoli F, Di Primio R, Offidani A. Effect of biologic therapies targeting tumour necrosis factor-\u03b1 on cutaneous mesenchymal stem cells in psoriasis. Br J Dermatol. 2012;167(1):68\u201376.","journal-title":"Br J Dermatol"},{"issue":"3","key":"4375_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1684\/ejd.2021.4050","volume":"31","author":"X Zhao","year":"2021","unstructured":"Zhao X, Jiao J, Li X, Hou R, Li J, Niu X, et al. Immunomodulatory effect of psoriasis-derived dermal mesenchymal stem cells on TH1\/TH17 cells. Eur J Dermatol. 2021;31(3):318\u201325.","journal-title":"Eur J Dermatol"},{"key":"4375_CR49","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1134\/S0006297920100065","volume":"85","author":"NV Vorobjeva","year":"2020","unstructured":"Vorobjeva NV, Chernyak BV. NETosis: molecular mechanisms, role in physiology and pathology. Biochem (Moscow). 2020;85:1178\u201390.","journal-title":"Biochem (Moscow)"},{"key":"4375_CR50","doi-asserted-by":"crossref","unstructured":"Niyonsaba F. The role of neutrophils and its NETosis in autoimmunity and autoinflammation. Frontiers Media SA; 2022. p. 1035624.","DOI":"10.3389\/fimmu.2022.1035624"},{"issue":"7","key":"4375_CR51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrneph.2016.71","volume":"12","author":"S Gupta","year":"2016","unstructured":"Gupta S, Kaplan MJ. The role of neutrophils and NETosis in autoimmune and renal diseases. Nat Rev Nephrol. 2016;12(7):402\u201313.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4375_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2012.01.013","volume":"143","author":"T N\u00e9meth","year":"2012","unstructured":"N\u00e9meth T, M\u00f3csai A. The role of neutrophils in autoimmune diseases. Immunol Lett. 2012;143(1):9\u201319.","journal-title":"Immunol Lett"},{"issue":"1","key":"4375_CR53","first-page":"3709749","volume":"2020","author":"W-M Wang","year":"2020","unstructured":"Wang W-M, Jin H-Z. Role of neutrophils in psoriasis. J Immunol Res. 2020;2020(1):3709749.","journal-title":"J Immunol Res"},{"key":"4375_CR54","doi-asserted-by":"crossref","unstructured":"Zhang B, Lai RC, Sim WK, Choo ABH, Lane EB, Lim SK. Topical application of mesenchymal stem cell exosomes alleviates the imiquimod induced Psoriasis-Like inflammation. Int J Mol Sci. 2021;22(2).","DOI":"10.3390\/ijms22020720"},{"issue":"8","key":"4375_CR55","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jcyt.2023.03.015","volume":"25","author":"RC Lai","year":"2023","unstructured":"Lai RC, Tan TT, Sim WK, Zhang B, Lim SK. A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis. Cytotherapy. 2023;25(8):815\u201320.","journal-title":"Cytotherapy"},{"key":"4375_CR56","doi-asserted-by":"publisher","first-page":"6961052","DOI":"10.1155\/2019\/6961052","volume":"2019","author":"M Chen","year":"2019","unstructured":"Chen M, Peng J, Xie Q, Xiao N, Su X, Mei H, et al. Mesenchymal stem cells alleviate Moderate-to-Severe psoriasis by reducing the production of type I interferon (IFN-I) by plasmacytoid dendritic cells (pDCs). Stem Cells Int. 2019;2019:6961052.","journal-title":"Stem Cells Int"},{"key":"4375_CR57","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fimmu.2020.00661","volume":"11","author":"Z Parackova","year":"2020","unstructured":"Parackova Z, Zentsova I, Vrabcova P, Klocperk A, Sumnik Z, Pruhova S, et al. Neutrophil extracellular trap induced dendritic cell activation leads to Th1 polarization in type 1 diabetes. Front Immunol. 2020;11:661.","journal-title":"Front Immunol"},{"issue":"11","key":"4375_CR58","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41419-022-05445-w","volume":"13","author":"Y Ding","year":"2022","unstructured":"Ding Y, Gong P, Jiang J, Feng C, Li Y, Su X, et al. Mesenchymal stem\/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis. Cell Death Dis. 2022;13(11):996.","journal-title":"Cell Death Dis"},{"key":"4375_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2021.07.014","volume":"73","author":"DA Constant","year":"2021","unstructured":"Constant DA, Nice TJ, Rauch I. Innate immune sensing by epithelial barriers. Curr Opin Immunol. 2021;73:1\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"4375_CR60","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/cei.13575","volume":"204","author":"P Chieosilapatham","year":"2021","unstructured":"Chieosilapatham P, Kiatsurayanon C, Umehara Y, Trujillo-Paez JV, Peng G, Yue H, et al. Keratinocytes: innate immune cells in atopic dermatitis. Clin Exp Immunol. 2021;204(3):296\u2013309.","journal-title":"Clin Exp Immunol"},{"key":"4375_CR61","doi-asserted-by":"crossref","unstructured":"Piipponen M, Li D, Land\u00e9n NX. The immune functions of keratinocytes in skin wound healing. Int J Mol Sci. 2020;21(22).","DOI":"10.3390\/ijms21228790"},{"key":"4375_CR62","doi-asserted-by":"publisher","first-page":"1286344","DOI":"10.3389\/fimmu.2023.1286344","volume":"14","author":"M Kamata","year":"2023","unstructured":"Kamata M, Tada Y. Crosstalk: keratinocytes and immune cells in psoriasis. Front Immunol. 2023;14:1286344.","journal-title":"Front Immunol"},{"issue":"5","key":"4375_CR63","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/002215540305100513","volume":"51","author":"AM Broome","year":"2003","unstructured":"Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem. 2003;51(5):675\u201385.","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"4375_CR64","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10753-023-01785-7","volume":"46","author":"X Ren","year":"2023","unstructured":"Ren X, Zhong W, Li W, Tang M, Zhang K, Zhou F, et al. Human umbilical Cord-Derived mesenchymal stem cells alleviate psoriasis through TNF-\u03b1\/NF-\u03baB\/MMP13 pathway. Inflammation. 2023;46(3):987\u20131001.","journal-title":"Inflammation"},{"issue":"1","key":"4375_CR65","doi-asserted-by":"publisher","first-page":"21897","DOI":"10.1038\/s41598-024-71251-3","volume":"14","author":"S Kushary","year":"2024","unstructured":"Kushary S, Cao X, Ghosh T, Roy PK. A mathematical insight to control the disease psoriasis using mesenchymal stem cell transplantation with a biologic inhibitor. Sci Rep. 2024;14(1):21897.","journal-title":"Sci Rep"},{"issue":"6970","key":"4375_CR66","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nature02238","volume":"427","author":"TR Mempel","year":"2004","unstructured":"Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature. 2004;427(6970):154\u20139.","journal-title":"Nature"},{"issue":"9","key":"4375_CR67","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41423-024-01167-5","volume":"21","author":"C Ngo","year":"2024","unstructured":"Ngo C, Garrec C, Tomasello E, Dalod M. The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond. Cell Mol Immunol. 2024;21(9):1008\u201335.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"4375_CR68","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nri2198","volume":"7","author":"E Bell","year":"2007","unstructured":"Bell E. Plasmacytoid dendritic cells in psoriasis. Nat Rev Immunol. 2007;7(11):839.","journal-title":"Nat Rev Immunol"},{"key":"4375_CR69","first-page":"281","volume":"9","author":"YS Lee","year":"2017","unstructured":"Lee YS, Sah SK, Lee JH, Seo KW, Kang KS, Kim TY. Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice. Biochem Biophys Rep. 2017;9:281\u20138.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"4375_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000330330","volume":"223","author":"P Quaglino","year":"2011","unstructured":"Quaglino P, Bergallo M, Ponti R, Barberio E, Cicchelli S, Buffa E, et al. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology. 2011;223(1):57\u201367.","journal-title":"Dermatology"},{"issue":"4","key":"4375_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/scrt75","volume":"2","author":"MM Duffy","year":"2011","unstructured":"Duffy MM, Ritter T, Ceredig R, Griffin MD. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther. 2011;2(4):34.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4375_CR72","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1002\/term.2423","volume":"12","author":"JY Kim","year":"2018","unstructured":"Kim JY, Park M, Kim YH, Ryu KH, Lee KH, Cho KA, et al. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1\/programmed death ligand-1 (PD-1\/PD-L1) pathway. J Tissue Eng Regen Med. 2018;12(2):e1022\u201333.","journal-title":"J Tissue Eng Regen Med"},{"key":"4375_CR73","doi-asserted-by":"publisher","first-page":"842813","DOI":"10.3389\/fcell.2022.842813","volume":"10","author":"W Zhang","year":"2022","unstructured":"Zhang W, Lin J, Shi P, Su D, Cheng X, Yi W, et al. Small extracellular vesicles derived from MSCs have Immunomodulatory effects to enhance delivery of ASO-210 for psoriasis treatment. Front Cell Dev Biol. 2022;10:842813.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"4375_CR74","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/JCI97426","volume":"128","author":"R Wu","year":"2018","unstructured":"Wu R, Zeng J, Yuan J, Deng X, Huang Y, Chen L, et al. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J Clin Invest. 2018;128(6):2551\u201368.","journal-title":"J Clin Invest"},{"key":"4375_CR75","doi-asserted-by":"crossref","unstructured":"Cuesta-Gomez N, Medina-Ruiz L, Graham GJ, Campbell JDM. IL-6 and TGF-\u03b2-Secreting Adoptively-Transferred murine mesenchymal stromal cells accelerate healing of Psoriasis-like skin inflammation and upregulate IL-17A and TGF-\u03b2. Int J Mol Sci. 2023;24(12).","DOI":"10.3390\/ijms241210132"},{"issue":"1","key":"4375_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13770-018-0165-3","volume":"16","author":"CH Kim","year":"2019","unstructured":"Kim CH, Lim CY, Lee JH, Kim KC, Ahn JY, Lee EJ. Human embryonic stem cells-Derived mesenchymal stem cells reduce the symptom of psoriasis in Imiquimod-Induced skin model. Tissue Eng Regen Med. 2019;16(1):93\u2013102.","journal-title":"Tissue Eng Regen Med"},{"issue":"48","key":"4375_CR77","doi-asserted-by":"publisher","first-page":"83419","DOI":"10.18632\/oncotarget.21379","volume":"8","author":"KA Cho","year":"2017","unstructured":"Cho KA, Park M, Kim YH, Ryu KH, Woo SY. Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity. Oncotarget. 2017;8(48):83419\u201331.","journal-title":"Oncotarget"},{"key":"4375_CR78","doi-asserted-by":"crossref","unstructured":"Wang Z-Z, Wang H-S. The role of osteoclasts in psoriatic arthritis. Int J Dermatology Venereol. 2021;4(4).","DOI":"10.1097\/JD9.0000000000000141"},{"issue":"2","key":"4375_CR79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jdermsci.2012.06.003","volume":"67","author":"M-J Kwon","year":"2012","unstructured":"Kwon M-J, Kim B, Lee YS, Kim T-Y. Role of superoxide dismutase 3 in skin inflammation. J Dermatol Sci. 2012;67(2):81\u20137.","journal-title":"J Dermatol Sci"},{"issue":"5","key":"4375_CR80","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/ars.2015.6368","volume":"24","author":"SK Sah","year":"2016","unstructured":"Sah SK, Park KH, Yun CO, Kang KS, Kim TY. Effects of human mesenchymal stem cells transduced with superoxide dismutase on Imiquimod-Induced Psoriasis-Like skin inflammation in mice. Antioxid Redox Signal. 2016;24(5):233\u201348.","journal-title":"Antioxid Redox Signal"},{"key":"4375_CR81","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.jtauto.2021.100130","volume":"4","author":"A Rajendeeran","year":"2021","unstructured":"Rajendeeran A, Tenbrock K. Regulatory T cell function in autoimmune disease. J Transl Autoimmun. 2021;4:100130.","journal-title":"J Transl Autoimmun"},{"issue":"3","key":"4375_CR82","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","volume":"160","author":"M Halabi-Tawil","year":"2009","unstructured":"Halabi-Tawil M, Ruemmele F, Fraitag S, Rieux\u2010Laucat F, Neven B, Brousse N, et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X\u2010linked (IPEX) syndrome. Br J Dermatol. 2009;160(3):645\u201351.","journal-title":"Br J Dermatol"},{"key":"4375_CR83","doi-asserted-by":"publisher","first-page":"102376","DOI":"10.1016\/j.jaut.2019.102376","volume":"110","author":"C Scheinecker","year":"2020","unstructured":"Scheinecker C, G\u00f6schl L, Bonelli M. Treg cells in health and autoimmune diseases: new insights from single cell analysis. J Autoimmun. 2020;110:102376.","journal-title":"J Autoimmun"},{"issue":"1","key":"4375_CR84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bjd.19380","volume":"184","author":"L Nussbaum","year":"2021","unstructured":"Nussbaum L, Chen Y, Ogg G. Role of regulatory T cells in psoriasis pathogenesis and treatment. Br J Dermatol. 2021;184(1):14\u201324.","journal-title":"Br J Dermatol"},{"issue":"4","key":"4375_CR85","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5021\/ad.2010.22.4.397","volume":"22","author":"W-J Yun","year":"2010","unstructured":"Yun W-J, Lee D-W, Chang S-E, Yoon G-S, Huh J-R, Won C-H, et al. Role of CD4\u2009+\u2009CD25high\u2009+\u2009FOXP3\u2009+\u2009regulatory T cells in psoriasis. Ann Dermatol. 2010;22(4):397\u2013403.","journal-title":"Ann Dermatol"},{"issue":"20","key":"4375_CR86","doi-asserted-by":"publisher","first-page":"eadg6007","DOI":"10.1126\/sciadv.adg6007","volume":"9","author":"W Zhang","year":"2023","unstructured":"Zhang W, Chen Y, Zhao Z, Zheng H, Wang S, Liao Z, et al. Adoptive Treg therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndrome. Sci Adv. 2023;9(20):eadg6007.","journal-title":"Sci Adv"},{"key":"4375_CR87","doi-asserted-by":"publisher","first-page":"6544514","DOI":"10.1155\/2022\/6544514","volume":"2022","author":"Z Ye","year":"2022","unstructured":"Ye Z, Liang Y, Lin B, Li Y, Chai X, Lian J, et al. Gingiva-Derived mesenchymal stem cells attenuate Imiquimod- (IMQ-) induced murine Psoriasis-Like skin inflammation. Stem Cells Int. 2022;2022:6544514.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4375_CR88","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","volume":"7","author":"L Cheng","year":"2022","unstructured":"Cheng L, Wang S, Peng C, Zou X, Yang C, Mei H, et al. Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1\/2a, single-arm study. Signal Transduct Target Therapy. 2022;7(1):263.","journal-title":"Signal Transduct Target Therapy"},{"issue":"17","key":"4375_CR89","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1089\/scd.2021.0129","volume":"30","author":"H Meng","year":"2021","unstructured":"Meng H, Wei F, Zhou Y, Hu L, Ge Z, Jin J, et al. Overexpression of hepatocyte growth factor in dental pulp stem cells ameliorates the severity of psoriasis by reducing inflammatory responses. Stem Cells Dev. 2021;30(17):876\u201389.","journal-title":"Stem Cells Dev"},{"issue":"10","key":"4375_CR90","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/1346-8138.16490","volume":"49","author":"J Jiao","year":"2022","unstructured":"Jiao J, Zhao X, Wang Y, Liang N, Li J, Yang X, et al. Normal mesenchymal stem cells can improve the abnormal function of T cells in psoriasis via upregulating transforming growth factor-\u03b2 receptor. J Dermatol. 2022;49(10):988\u201397.","journal-title":"J Dermatol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04375-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:02:53Z","timestamp":1747242173000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04375-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4375"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04375-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI use declaration"}}],"article-number":"241"}}